Searchable abstracts of presentations at key conferences in endocrinology

ea0084ps3-15-134 | Thyroid Cancer Diagnosis & Treatment | ETA2022

Patient-reported outcomes (PROS) from patients with RET-mutant medullary thyroid cancer (MTC) and ret fusion-positive TC treated with pralsetinib in the arrow trial

Hadoux Julien , I Hu Mimi , S. Brose Marcia , Garralda Elena , Spitzweg Christine , Reguart Noemi , Do Cao Christine , D. Forster Martin , Alonso-Gordoa Teresa , Barata Teresa , Scalori Astrid , Zalutskaya Alena , Trask Peter , Subbiah Vivek

Objectives: RET alterations are targetable oncogenic drivers in TC. Patients with TC, especially those with MTC treated with the multikinase inhibitors cabozantinib and/or vandetanib (C/V), often experience significant treatment-related side effects. Pralsetinib, a selective RET tyrosine kinase inhibitor, showed efficacy in patients with RET-altered TC from the phase 1/2 ARROW trial (NCT03037385). We present the impact of pralsetinib on PROs in patients with ...

ea0089o1 | Other | NANETS2022

Efficacy and Toxicity of Anti-Vascular Endothelial Growth Factor (VEGF) Receptor Tyrosine Kinase Inhibitors (TKIs) in Neuroendocrine Tumors (NETs) – A Systematic Review and Meta-Analysis

Das, MD, MSCI Satya , Phillips, MSPH Sharon , M Lebeck Lee, MD Cody , Agarwal, MD, MSCI Rajiv , Bergsland, MD Emily , Strosberg, MD Jonathan , A. Chan, MD, MPH Jennifer , LaFerriere, MLIS Heather , A. Ramirez, DO Robert , Berlin, MD Jordan , Arvind Dasari, MD, MS and

Background: Although anti-VEGF RTKIs have been tested in patients with NETs over the last 2 decades, no study to date has benchmarked efficacy and toxicity of these drugs in this patient population.Methods: A literature search was performed to identify all phase II and phase III studies of anti-VEGF RTKIs in patients with NETs published between January 1, 2000 – July 31, 2021. Major trial databases (e.g. Medline, EMBASE, Cumulative Index of Nursing ...

ea0063p352 | Thyroid 1 | ECE2019

The relationship between thyroid receptor antibody and anti mullerian hormone in Graves’ disease

Demir Keziban , Kursat Hakan , Yazici Sevde , Pişkinpaşa Hamide , Bozkir Evin , Esen Ayşe , Akdeniz Yasemin , Doğanşen Sema , Hurşitoğlu Mehmet , Kural Alev , Mert Meral

Introduction and Aim: Thyroid dysfunction is the most common autoimmune endocrine disorder in women of reproductive age. Autoimmune thyroid disease is related to menstrual irregularities, anovulation and infertility. Thyroid dysfunction is thought to disrupt follicular growth and maturation. Autoimmunity may have a negative effect on fertility, independent of age. The relation between TSH (Thyroid Stimulant Hormone), thyroid antibodies and AMH (anti-mullerian hormone) is a top...

ea0049ep897 | Neuroendocrinology | ECE2017

The prevalence of colorectal cancer and colon polyps in acromegaly: thirty years’ experience of a tertiary referral center

Gomes Vania , Barreiros Luis , Barreiros Eduardo , Ferreira Florbela , Gomes Ana , Martins Ana Filipa , Osorio Ana Sofia , Wessling Ana , Silvestre Catarina , Reis Dinis , Nobre Ema , Carvalho Maria Raquel , Mascarenhas Mario , Vale Sonia do , Miguens Jose , Bugalho Maria Joao

Introduction: Several studies suggest a higher risk of colorectal cancer (CRC) and colon polyps (CP) in acromegaly, however there is still controversy regarding associated factors (AF) able to contribute for its development. Data on the prevalence of CRC and CP in Portuguese patients with acromegaly are limited.Objectives: To assess the prevalence of CRC and CP in acromegalic patients and compare to the normal Portuguese population. To determine the rele...

ea0049ep898 | Neuroendocrinology | ECE2017

Acromegaly and malignant neoplasms

Gomes Vania , Barreiros Eduardo , Barreiros Luis , Ferreira Florbela , Gomes Ana , Martins Ana Filipa , Osorio Ana Sofia , Wessling Ana , Silvestre Catarina , Reis Dinis , Nobre Ema , Carvalho Maria Raquel , Mascarenhas Mario , do Vale Sonia , Miguens Jose , Bugalho Maria Joao

Introduction: Acromegaly is a rare disease resulting from pathological oversecretion of growth hormone (GH) and insulin-like growth factor-1 (IGF-1). The clinical spectrum includes cardiovascular and respiratory diseases but also increased risk of benign and malignant neoplasms.Objectives: Evaluate the prevalence of cancer and seek for associated factors in acromegaly.Methods: Retrospective study of 94 patients with acromegaly trea...

ea0041ep589 | Endocrine tumours and neoplasia | ECE2016

Proposal of a two-step dynamic prognostic stratification for stage IV sporadic pancreatic neuroendocrine tumors

Marotta Vincenzo , Walter Thomas , Do Cao Christine , Tafuto Salvatore , Montesarchio Vincenzo , Arfi-Rouche Julia , Valette Pierre Jean , Lombard-Bohas Catherine , Leteurtre Emmanuelle , Borget Isabelle , Scoazec Jean Yves , Ducreux Michel , Faggiano Antongiulio , Colao Annamaria , Baudin Eric

Purpose: To validate a prognostic stratification system of overall survival (OS) in stage IV pancreatic neuroendocrine tumors (pNETs) naïve of therapy by analyzing 1) prognostic parameters at the time of stage IV diagnosis; 2) the role of spontaneous tumor slope.Patients and Methods: Multicenter retrospective study including consecutive patients diagnosed with stage IV pNET from January 1997 to March 2014. Inclusion criteria were: 1. pNET w...

ea0032p11 | Adrenal cortex | ECE2013

Molecular screening for personalized treatment approach in advanced adrenocortical cancer

De Martino Maria Cristina , Al Ghuzlan Abir , Do Cao Christine , Assie Guillaume , Scoazec Jean-Yves , Leboulleux Sophie , Aubert Sebastien , Libe Rossella , Nozieres Cecile , Pattou Francois , Borson-Chazot Francoise , Pivonello Rosario , Mazoyer Clement , Bertherat Jerome , Schlumberger Martin , Lacroix Ludovic , Baudin Eric

Propose: To screen for the presence of putative targets for new treatments in a large cohort of advanced adrenocortical cancer (ACC)Experimental design: In 40 adult stage III-IV ACC primary samples, we used comparative genomic hybridization (CGH) and hotspot gene sequencing (with Ion Torrent) to describe the presence of copy number abnormalities and mutations in more than 40 genes involved in cancer development and putative drug sensitivity (HER2; EGFR; ...

ea0032p746 | Obesity | ECE2013

Green tea catechins attenuate high-fat diet effects related to obesity and diabetes without effect hypothalamic expression of TLR4 pathway or serotoninergic 1B and 2C receptors

Okuda Marcos Hiromu , Alves de Santana Aline , Moreno Mayara Franzoi , Hachul Ana Claudia , Neto Nelson Inacio , dos Santos Bruno , Oller do Nascimento Claudia Maria , Zemdegs Juliane , Ribeiro Eliane Beraldi , Oyama Lila Missae

Many mechanisms are proposed for green tea’s role as anti-obesity and anti-diabetic natural product. Two of them involve the hypothalamic control of energy balance: i) high-fat diets (HFD) rich in saturated fats induce low-grade inflammation, leading to leptin and insulin resistance; ii) serotonin receptors (SR) 1B and 2C activation have anorexigenic effects, SR2C activation improves insulin sensitivity, and HFD can also impair this system. We investigated the effects of ...

ea0026p30 | Adrenal cortex | ECE2011

Is plasma mitotane level >30 mg/l a serious adverse event in patients with adrenocortical carcinoma (ACC)?: a retrospective analysis of the French COMETE network

Mauclere-Denost S M D , Tabarin A T , Drui D D , Chaillous L C , Salenave S S , Leboulleux S L , Chabre O C , Do-Cao C D C , Dubourg H D , Cuvelier M L C , Young J Y , Baudin E B

Background: Mitotane antitumor efficacy is related to plasma levels. Objective responses have been associated with mitotane plasma levels >14 mg/l. However, high plasma levels >20 or >30 mg/l are at higher risk of toxicity, especially neurotoxicity. National-based survey is lacking to evaluate the frequency and severity of high mitotane plasma levels. Our aim was to retrospectively describe serious adverse events (SAE).Methods: Mitotane plasm...

ea0022p120 | Bone/Calcium | ECE2010

Estradiol and testosterone levels in diabetic type 2 men with low bone density and osteoporosis

Mascarenhas Mario Rui , Barbosa Ana Paula , Nobre Ema , Goncalves Ana , Simoes Vera , Camolas Jose , Carvalho Maria Raquel , Ferreira Joana , Vieira Joao , Pinto David Santos , Bicho Manuel , do Carmo Isabel

Osteoporosis and diabetes mellitus type 2 (DM2) have severe health consequences, with high morbidity and mortality risks.Aims: To study the differences of the sex steroid hormones levels and the free androgen index (FAI) in DM2 men with low BMD and osteoporosis and their relationships with BMD.Materials and methods: In 317 men with DM2, the BMD (g/cm2) was evaluated at the lumbar spine (L1-L4), at t...